Literature DB >> 11968057

Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy.

Daniel D Mikol1, Steven S Scherer, Sara J Duckett, Hoylond L Hong, Eva L Feldman.   

Abstract

The caveolins are a family of related proteins that form the structural framework of caveolae. They have been implicated in the regulation of signal transduction, cell cycle control, and cellular transport processes, particularly cholesterol trafficking. Caveolin-1 is expressed by a variety of cell types, including Schwann cells, although its expression is greatest in differentiated cell types, such as endothelial cells and adipocytes. In the present work, we characterize caveolin-1 expression both during rat sciatic nerve development and after axotomy. Schwann cells express little caveolin-1 on postnatal days 1 and 6. By P30, myelinating Schwann cells express caveolin-1, which is localized in the outer/abaxonal myelin membranes as well as intracellularly. After axotomy, Schwann cell caveolin-1 expression in the distal nerve stump decreases as Schwann cells revert to a premyelinating (p75-positive) phenotype; residual caveolin-1 within the nerve largely localizes to myelin debris and infiltrating macrophages. We speculate that caveolin-1 plays a role in the biology of myelinating Schwann cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968057     DOI: 10.1002/glia.10063

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

Review 1.  White matter rafting--membrane microdomains in myelin.

Authors:  Lillian S Debruin; George Harauz
Journal:  Neurochem Res       Date:  2006-09-21       Impact factor: 3.996

Review 2.  Caveolins and lung function.

Authors:  Nikolaos A Maniatis; Olga Chernaya; Vasily Shinin; Richard D Minshall
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination.

Authors:  Cuijuan Yu; Shefali Rouen; Rick T Dobrowsky
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

4.  Differential cell-specific location of Cav-1 and Ca(2+)-ATPase in terminal Schwann cells and mechanoreceptive Ruffini endings in the periodontal ligament of the rat incisor.

Authors:  Naoyuki Iizuka; Akiko Suzuki; Kayoko Nozawa-Inoue; Yoshiro Kawano; B G T L Nandasena; Takashi Okiji; Takeyasu Maeda
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

5.  Proteome profile of peripheral myelin in healthy mice and in a neuropathy model.

Authors:  Sophie B Siems; Olaf Jahn; Maria A Eichel; Nirmal Kannaiyan; Lai Man N Wu; Diane L Sherman; Kathrin Kusch; Dörte Hesse; Ramona B Jung; Robert Fledrich; Michael W Sereda; Moritz J Rossner; Peter J Brophy; Hauke B Werner
Journal:  Elife       Date:  2020-03-04       Impact factor: 8.140

6.  Acoustic Waves in Axonal Membrane and Caveolins are the New Targets for Pain Treatment with High Frequency Ultrasound.

Authors:  Ilja Kruglikov
Journal:  J Pain Res       Date:  2020-11-02       Impact factor: 3.133

7.  Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.

Authors:  James F McGuire; Shefali Rouen; Eric Siegfreid; Douglas E Wright; Rick T Dobrowsky
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

Review 8.  The less-often-traveled surface of stem cells: caveolin-1 and caveolae in stem cells, tissue repair and regeneration.

Authors:  Natasha Baker; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2013-07-30       Impact factor: 6.832

9.  Transcriptional regulation induced by cAMP elevation in mouse Schwann cells.

Authors:  Daniela Schmid; Thomas Zeis; Nicole Schaeren-Wiemers
Journal:  ASN Neuro       Date:  2014-04-30       Impact factor: 4.146

Review 10.  Role of Caveolin-1 in Diabetes and Its Complications.

Authors:  Dania Haddad; Ashraf Al Madhoun; Rasheeba Nizam; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.